Faculty Disclosures

Article Outline

 

The authors who contributed to this publication have disclosed the following industry relationships:

Juan J. Badimon, PhD, has served as an advisory board participant (honorarium) for AstraZeneca Pharmaceuticals LP, Lilly-Sankyo, Pfizer Inc, and sanofi aventis.

Harold E. Bays, MD, has served on the Speakers' Bureau and as consultant/advisor for Abbott Laboratories, Arena Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Daiichi Sankyo, Inc., DSM N.V., Essentialis, Inc., Ironwood Pharmaceuticals, Inc., Merck & Co., Inc., Merck/Schering-Plough, Inc., Metabasis Therapeutics, Inc., Microbia, Novartis Pharmaceuticals, NicOx, Pfizer Inc, Reliant Pharmaceuticals, Inc., Schering-Plough Corporation, GlaxoSmithKline, Surface Logix, Inc., and Takeda Pharmaceutical Company Limited. He has received research grants from Abbott Laboratories, Aegerion Pharmaceuticals, Amylin, Arena Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Inc., Eli Lilly, Genentech, Inc., GlaxoSmithKline, Hoechst Roussel, Hoffman-LaRoche, Inc., InterMune, Ironwood Pharmaceuticals, Inc., Johnson & Johnson, Kos Pharmaceuticals, Inc., Kyorin Pharmaceutical Co., Ltd., Merck & Co., Inc., Merck/Schering-Plough, Inc., Metabolex Inc., Microbia, Neuromed Pharmaceuticals, NicOx, Novartis Pharmaceuticals, Obecure, Orexigen Therapeutics, Pfizer Inc, Pliva, Purdue Pharma LP, Reliant Pharmaceuticals, Inc., sanofi aventis, Sciele Pharma, Shionogi & Co., Ltd., Schering-Plough Corporation, Takeda Pharmaceutical Company Limited, TAP Pharmaceutical Products., Inc., and Wyeth-Ayerst Laboratories.

Michael H. Davidson, MD, serves on the Speakers' Bureau for Abbott Laboratories, AstraZeneca Pharmaceuticals LP, Daiichi Sankyo, Inc., diaDexus, Merck & Co., Inc., Merck/Schering-Plough, Inc., Oscient Pharmaceuticals, Pfizer Inc, Reliant Pharmaceuticals, Inc., and Takeda Pharmaceutical Company Limited. He is a consultant for Abbott Laboratories, AstraZeneca Pharmaceuticals LP, Daiichi-Sankyo, Inc., diaDexus, Merck & Co., Inc., Merck/Schering-Plough, Inc., Pfizer Inc, Reliant Pharmaceuticals Inc., Roche Pharmaceuticals, sanofi aventis, and Takeda Pharmaceutical Company Limited. Dr. Davidson has been an advisory board participant for Abbott Laboratories, Access Health, AtheroGenics, Inc., AstraZeneca Pharmaceuticals LP, Daiichi-Sankyo, Inc., Merck & Co., Inc., Merck/Schering-Plough, Inc., Oscient Pharmaceuticals, Pfizer Inc, Reliant Pharmaceuticals, Inc., Roche Pharmaceuticals, Takeda Pharmaceutical Company Limited, and Xinthria Pharmaceuticals and has received research support from Abbott Laboratories, AstraZeneca Pharmaceuticals LP, Daiichi-Sankyo, Inc., Merck & Co., Inc., Merck/Schering-Plough, Inc., Pfizer Inc, Reliant Pharmaceuticals, Inc., Roche Pharmaceuticals, and Takeda Pharmaceutical Company Limited. In addition, he is a member of Equity/Boards of Directors for Angiogen, LLC (Board of Directors), Sonogene Ltd. (Board of Directors), and Professional Evaluation, Inc. (Chief Medical Officer).

Kathleen M. Fox, PhD, is a consultant for and has received research support from AstraZeneca Pharmaceuticals LP.

Sanjay K. Gandhi, PhD, is an employee of AstraZeneca Pharmaceuticals LP.

Mario J. Garcia, MD, is a consultant for Philips Medical Systems and BG Medicine and has received honoraria from Abbott Laboratories and AstraZeneca Pharmaceuticals LP.

Borja Ibañez, MD, has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.

William Insull, Jr., MD, serves on the Speakers' Bureau for Abbott Laboratories, Merck & Co., Inc., and Schering-Plough Corporation and as a consultant/advisory board participant for Daiichi Sankyo, Inc., Merck & Co., Inc., and Merck/Schering-Plough, Inc. He is an investigator for Pfizer Inc and has received research support from AstraZeneca Pharmaceuticals LP, Kos Pharmaceuticals, Inc., Merck & Co., Inc., and Pfizer Inc. In addition, Dr. Insull has received honoraria from Merck & Co., Inc., and from Merck/Schering-Plough, Inc., and is an editor/writer for AstraZeneca Pharmaceuticals LP.

Sandra J. Lewis, MD, is a consultant and investigator for AstraZeneca Pharmaceuticals LP and Pfizer Inc, and serves as a consultant for Merck & Co., Inc.

Robert Ohsfeldt, PhD, serves as a consultant for Pfizer Inc, and has received research support from Amgen, AstraZeneca Pharmaceuticals LP, and Teva Specialty Pharmaceuticals.